- In January 2024, Botaniex, Inc. partnered with a major pharmaceutical company to enhance the global distribution of proanthocyanidin-based dietary supplements. This collaboration leverages Botaniex’s expertise in botanical extracts to expand the availability of antioxidant-rich products, catering to health-conscious consumers in emerging markets. The partnership strengthens Botaniex’s supply chain and market reach, particularly in regions with increasing demand for nutraceuticals. By integrating advanced research and distribution strategies, Botaniex aims to drive innovation in the health supplement industry
- In March 2023, Nexira, a global leader in natural ingredients and botanical extracts, acquired Polyphenolics, a supplier of proanthocyanidins derived from grape seeds. This strategic move expands Nexira’s product portfolio and strengthens its presence in the dietary supplement and functional food markets. The acquisition positions Nexira to meet rising consumer demand for high-purity proanthocyanidin products in North America and beyond, reinforcing its commitment to innovation and sustainability in natural health solutions
- In February 2023, Naturex S.A. introduced Pycnogenol, a proanthocyanidin-based product derived from pine bark. This botanical extract is designed for applications in dietary supplements, functional foods, and cosmetics, offering potent antioxidant benefits for cardiovascular health and skin protection. The launch aligns with increasing consumer demand for natural, plant-based ingredients, reinforcing Naturex’s competitive position in the global market. Pycnogenol’s formulation supports wellness and skincare innovations, catering to health-conscious consumers
- In April 2023, Indena S.p.A., a leader in plant-derived active ingredients, introduced a new range of proanthocyanidin products for dietary supplements, functional foods, and cosmetics. Developed using advanced extraction techniques, these products meet the growing demand for high-quality, bioavailable antioxidants. The launch strengthens Indena’s portfolio, catering to health-conscious consumers and reinforcing its innovation-driven market presence. Indena continues to expand its expertise in botanical derivatives, ensuring excellence in natural health solutions
- In September 2022, Eevia Health Oy partnered with a leading university to research the efficacy of Type A proanthocyanidin extracts, particularly from cranberries. This collaboration aims to validate health benefits, such as urinary tract infection prevention, supporting product development. The partnership strengthens Eevia’s position in the nutraceutical market by enhancing scientific credibility and consumer trust. The study focuses on the antioxidant and anti-inflammatory properties of proanthocyanidins, contributing to advancements in natural health solutions
